Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Fluticasone Propionate
Therapeutic Area : Pulmonary/Respiratory Diseases
Study Phase : Preclinical
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : In mouse model, prophylactic treatment with APT-101 (fluticasone propionate) for 21 days resulted in significant reduction in development of fibrosis and apoptosis compared to placebo as well as to active control, pirfenidone, approved treatment for pulm...
Product Name : Undisclosed
Product Type : Steroid
Upfront Cash : Inapplicable
August 02, 2022
Lead Product(s) : Fluticasone Propionate
Therapeutic Area : Pulmonary/Respiratory Diseases
Highest Development Status : Preclinical
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
